Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-18T11:27:04.541Z Has data issue: false hasContentIssue false

Chapter 9 - Mapping Metabolism and Inflammation in Epilepsy

from Part II - Modeling Epileptogenic Lesions and Mapping Networks

Published online by Cambridge University Press:  07 January 2019

By
Csaba Juhász  and
Sandeep Mittal
Edited by
Andrea Bernasconi ,
Neda Bernasconi  and
Matthias Koepp
Andrea Bernasconi
Affiliation:
Montreal Neurological Institute, McGill University
Neda Bernasconi
Affiliation:
Montreal Neurological Institute, McGill University
Matthias Koepp
Affiliation:
Institute of Neurology, University College London
Get access
Type
Chapter
Information
Imaging Biomarkers in Epilepsy , pp. 95 - 107
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Vezzani, A, Granata, T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia. 2005;46:1724–43.CrossRefGoogle ScholarPubMed
Marchi, N, Granata, T, Janigro, D. Inflammatory pathways of seizure disorders. Trends Neurosci. 2014;37:55–65.Google Scholar
Otáhal, J, Folbergrová, J, Kovacs, R, et al. Epileptic focus and alteration of metabolism. Int Rev Neurobiol. 2014;114:209–43.CrossRefGoogle ScholarPubMed
Kuhl, DE, Engel, J Jr, Phelps, ME, et al. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol. 1980;8:348–60.Google Scholar
Mazziotta, JC, Engel, J Jr. The use and impact of positron computed tomography scanning in epilepsy. Epilepsia. 1984;25(suppl 2):S86–104.Google Scholar
Johnson, EW, de Lanerolle, NC, Kim, JH, et al. “Central” and “peripheral” benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology. 1992;42:811–5.Google Scholar
Kumlien, E, Hilton-Brown, P, Spännare, B, et al. In vitro quantitative autoradiography of [3H]-L-deprenyl and [3H]-PK11195 binding sites in human epileptic hippocampus. Epilepsia. 1992;33:610–7.CrossRefGoogle ScholarPubMed
Vezzani, A, French, J, Bartfai, T, et al. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7:31–40.CrossRefGoogle ScholarPubMed
Amhaoul, H, Staelens, S, Dedeurwaerdere, S. Imaging brain inflammation in epilepsy. Neuroscience. 2014;279:238–52.Google Scholar
O’Brien, TJ, Jupp, B. In-vivo imaging with small animal FDG-PET: a tool to unlock the secrets of epileptogenesis? Exp Neurol. 2009;220:1–4.Google Scholar
Pitkänen, A, Lukasiuk, K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 2011;10:173–86.Google Scholar
Engel, J Jr, Pitkanen, A, Loeb, JA, et al. Epilepsy biomarkers. Epilepsia. 2013;54(suppl 4):61–9.Google Scholar
Guo, Y, Gao, F, Wang, S, et al. In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: an 18F-fluorodeoxyglucose-small animal positron emission tomography study. Neuroscience. 2009;162:972–9.CrossRefGoogle ScholarPubMed
Lee, EM, Park, GY, Im, KC, et al. Changes in glucose metabolism and metabolites during the epileptogenic process in the lithium-pilocarpine model of epilepsy. Epilepsia. 2012;53:860–9.Google Scholar
Jupp, B, Williams, B, Binns, D, et al. Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE. Epilepsia. 2012;53:1233–44.Google Scholar
Shultz, SR, Cardamone, L, Liu, YR, et al. Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome? Epilepsia. 2013;54:1240–50.Google Scholar
Benedek, K, Juhász, C, Muzik, O, et al. Metabolic changes of subcortical structures in intractable focal epilepsy. Epilepsia. 2004;45:1100–5.Google Scholar
Keller, SS, O’Muircheartaigh, J, Traynor, C, Towgood, K, Barker, GJ, Richardson, MP. Thalamotemporal impairment in temporal lobe epilepsy: a combined MRI analysis of structure, integrity, and connectivity. Epilepsia. 2014;55(2):306–15.Google Scholar
Camilo, O, Goldstein, LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35:1769–75.CrossRefGoogle ScholarPubMed
Lossius, MI, Rønning, OM, Slapø, GD, et al. Poststroke epilepsy: occurrence and predictors—a long-term prospective controlled study (Akershus Stroke Study). Epilepsia. 2005;46:1246–51.Google Scholar
Wang, H, Xin, T, Sun, X, et al. Post-traumatic seizures—a prospective, multicenter, large case study after head injury in China. Epilepsy Res. 2013;107:272–8.Google Scholar
Ville, D, Enjolras, O, Chiron, C, et al. Prophylactic antiepileptic treatment in Sturge-Weber disease. Seizure. 2002;11:145–50.CrossRefGoogle ScholarPubMed
Jóźwiak, S, Kotulska, K, Domanska-Pakiela, D, et al. Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol. 2011;15:424–31.CrossRefGoogle ScholarPubMed
Alkonyi, B, Chugani, HT, Juhász, C. Transient focal increase of interictal glucose metabolism in Sturge-Weber syndrome: implications for epileptogenesis. Epilepsia. 2011;52:1265–72.Google Scholar
Chugani, HT, Mazziotta, JC, Phelps, ME. Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr. 1989; 114:244–53.Google Scholar
Juhász, C, Hu, J, Xuan, Y, Chugani, H. Imaging increased glutamate in children with Sturge-Weber syndrome: association with epilepsy severity. Epilepsy Res. 2016;122:66–72.CrossRefGoogle ScholarPubMed
Ashwal, S, Holshouser, B, Tong, K, et al. Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury. J Neurotrauma. 2004;21:1539–52.Google Scholar
Gaillard, WD, Kopylev, L, Weinstein, S, et al. Low incidence of abnormal (18)FDG-PET in children with new-onset partial epilepsy: a prospective study. Neurology. 2002;58:717–22.CrossRefGoogle ScholarPubMed
Weitemeyer, L, Kellinghaus, C, Weckesser, M, et al. The prognostic value of [18F]FDG-PET in nonrefractory partial epilepsy. Epilepsia. 2005;46:1654–60.Google Scholar
Gaillard, WD, Weinstein, S, Conry, J, et al. Prognosis of children with partial epilepsy: MRI and serial 18FDG-PET. Neurology. 2007;68:655–9.Google Scholar
Henry, TR. Positron emission tomography: glucose metabolism studies in temporal lobe epilepsy. In: Chugani, HT, ed. Neuroimaging in Epilepsy. New York: Oxford University Press; 2011:122–40.Google Scholar
Juhász, C, Chugani, HT. Positron emission tomography: glucose metabolism in extratemporal lobe epilepsy. In: Chugani, HT, ed. Neuroimaging in Epilepsy. New York: Oxford University Press; 2011:141–55.Google Scholar
Tenney, JR, Rozhkov, L, Horn, P, et al. Cerebral glucose hypometabolism is associated with mitochondrial dysfunction in patients with intractable epilepsy and cortical dysplasia. Epilepsia. 2014;55:1415–22.Google Scholar
Swartz, BE, Brown, C, Mandelkern, MA, et al. The use of 2-deoxy-2-[18F]fluoro-D-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy. Mol Imaging Biol. 2002;4:245–52.Google Scholar
Benedek, K, Juhász, C, Chugani, DC, et al. Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol. 2006;21:26–31.Google Scholar
Juhász, C, Batista, CE, Chugani, DC, et al. Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome. Eur J Paediatr Neurol. 2007;11:277–84.Google Scholar
Choi, JY, Kim, SJ, Hong, SB, et al. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging. 2003;30:581–7.Google Scholar
Spanaki, MV, Kopylev, L, DeCarli, C, et al. Postoperative changes in cerebral metabolism in temporal lobe epilepsy. Arch Neurol. 2000;57:1447–52.Google Scholar
Joo, EY, Hong, SB, Han, HJ, et al. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain. 2005;128(pt 8):1802–10.Google Scholar
Takaya, S, Mikuni, N, Mitsueda, T, et al. Improved cerebral function in mesial temporal lobe epilepsy after subtemporal amygdalohippocampectomy. Brain. 2009;132(pt 1):185–94.Google Scholar
Talanow, R, Ruggieri, P, Alexopoulos, A, et al. PET manifestation in different types of pathology in epilepsy. Clin Nucl Med. 2009;34:670–4.Google Scholar
Sarria-Estrada, S, Toledo, M, Lorenzo-Bosquet, C, et al. Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radiol. 2014;69:795–803.Google Scholar
Dedeurwaerdere, S, Callaghan, PD, Pham, T, et al. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Res. 2012;2:60.Google Scholar
Van Camp, N, Boisgard, R, Kuhnast, B, et al. In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C] CLINME and [(11)C]-PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging. 2010;37:962–72.Google Scholar
Bogdanović, RM, Syvänen, S, Michler, C, et al. (R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. Neuropharmacology. 2014;85:104–12.Google Scholar
Banati, RB, Goerres, GW, Myers, R, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis. Neurology. 1999;53:2199–203.Google Scholar
Kumar, A, Chugani, HT, Luat, A, et al. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol. 2008;38:439–42.Google Scholar
Kreisl, WC, Fujita, M, Fujimura, Y, et al. Comparison of [11C]-(R)-PK11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker. NeuroImage. 2010;49:2924–32.Google Scholar
Butler, T, Ichise, M, Teich, AF, et al. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging. 2013;23:129–31.CrossRefGoogle Scholar
Hirvonen, J, Kreisl, WC, Fujita, M, et al. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med. 2012;53:234–40.Google Scholar
Nash, TE, Mahanty, S, Loeb, JA, et al. Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia. 2015;56:177–83.Google Scholar
Fujita, M, Mahanty, S, Zoghbi, SS, et al. PET reveals inflammation around calcified Taenia solium granulomas with perilesional edema. PLOS ONE. 2013;8:e74052.CrossRefGoogle ScholarPubMed
Kaim, AH, Weber, B, Kurrer, MO, et al. 18F-FDG and 18F-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging. 2002;29:648–54.Google Scholar
Stöber, B, Tanase, U, Herz, M, et al. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging. 2006;33:932–9.Google Scholar
Sasaki, M, Kuwabara, Y, Yoshida, T, et al. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. J Nucl Med. 1998;39:974–7.Google Scholar
Madakasira, PV, Simkins, R, Narayanan, T, et al. Cortical dysplasia localized by [11C]methionine positron emission tomography: case report. AJNR Am J Neuroradiol. 2002;23:844–6.Google Scholar
Phi, JH, Paeng, JC, Lee, HS, et al. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine PET. J Nucl Med. 2010;51:728–34.Google Scholar
Diksic, M, Nagahiro, S, Sourkes, TL, et al. A new method to measure brain serotonin synthesis in vivo. I. Theory and basic data for a biological model. J Cereb Blood Flow Metab. 1990;10:1–12.Google Scholar
Diksic, M, Tohyama, Y, Takada, A. Brain net unidirectional uptake of alpha-[14C]methyl-L-tryptophan (alpha-MTrp) and its correlation with regional serotonin synthesis, tryptophan incorporation into proteins, and permeability surface area products of tryptophan and alpha-MTrp. Neurochem Res. 2000;25:1537–46.CrossRefGoogle ScholarPubMed
Muzik, O, Chugani, DC, Chakraborty, P, et al. Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab. 1997;17:659–69.Google Scholar
Trottier, S, Evrard, B, Vignal, JP, et al. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia. Epilepsy Res. 1996;25:79–106.Google Scholar
Chugani, DC, Muzik, O. Alpha[C-11]methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab. 2000;20:2–9.Google Scholar
Chugani, DC. Alpha-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions. Biomarkers Med. 2011; 5:567–75.Google Scholar
Feldblum, S, Rougier, A, Loiseau, H, et al. Quinolinic acid phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia. 1988;29:523–9.CrossRefGoogle ScholarPubMed
Heyes, MP, Wyler, AR, Devinsky, O, et al. Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia. 1990;31:172–7.CrossRefGoogle ScholarPubMed
Munn, DH, Mellor, AL. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest. 2007;117:1147–54.Google Scholar
Pilotte, L, Larrieu, P, Stroobant, V, et al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci USA. 2012;109:2497–502.Google Scholar
Vacchelli, E, Aranda, F, Eggermont, A, et al. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2014;3:e957994.Google Scholar
Chugani, DC, Chugani, HT, Muzik, O, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol. 1998;44:858–66.Google Scholar
Fedi, M, Reutens, DC, Andermann, F, et al. Alpha-[11C]-methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res. 2003;52:203–13.Google Scholar
Rubí, S, Costes, N, Heckemann, RA, et al. Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy. Epilepsia. 201;54:2143–50.Google Scholar
Chugani, HT, Luat, AF, Kumar, A, et al. a-[11C]-Methyl-L- tryptophan PET in. 191 patients with tuberous sclerosis complex. Neurology. 2013;81:674–80.Google Scholar
Kagawa, K, Chugani, DC, Asano, E, et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol. 2005;20:429–38.Google Scholar
Fedi, M, Reutens, D, Okazawa, H, et al. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology. 2001;57:1629–36.Google Scholar
Juhász, C, Chugani, DC, Muzik, O, et al. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology. 2003;60:960–8.Google Scholar
Chugani, HT, Kumar, A, Kupsky, W, et al. Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia. 2011;52:1692–8.Google Scholar
Natsume, J, Kumakura, Y, Bernasconi, N, et al. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology. 2003;60:756–61.Google Scholar
Asano, E, Chugani, DC, Muzik, O, et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology. 2000;54:1976–84.Google Scholar
Alkonyi, B, Mittal, S, Zitron, I, et al. Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors. J Neurooncol. 2012;107:365–72.Google Scholar
Juhász, C, Chugani, DC, Muzik, O, et al. Decreased GABAA receptor binding and increased uptake of α[11C]methyl-L-tryptophan on PET can independently identify human epileptogenic cortex. Neurology. 2002;58(suppl 3):A150.Google Scholar
Ravizza, T, Boer, K, Redeker, S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis. 2006;24:128–43.Google Scholar
Boer, K, Jansen, F, Nellist, M, et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 2008;78:7–21.Google Scholar
Iyer, A, Zurolo, E, Spliet, WG, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia. 2010;51:1763–73.Google Scholar
Shu, HF, Zhang, CQ, Yin, Q, et al. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol. 2010;69:838–49.Google Scholar
Juhász, C, Buth, A, Chugani, DC, et al. Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus. Neurosurg Focus. 2013b;34(6):E5.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×